Team

Rapid Pharma Development Team

Dr. Robert Hett

Managing Partner


Email: robert.hett@rpd-ch.com

Phone:+41 61 599 4886

Mobile CH: +41 79 471 9502

Mobile D: +49 1761 471 9502

Education:
Chemist RWTH-Aachen
Postdoc University of Notre Dame, USA

Key experience:
Business Development, Process Chemistry, API Development, GMP, CRO Management, CMC Project Management, Audits, Patents, Publications, Board member of OPRD

Previous Experience:

Carbogen: Site Manager, of a pilot plant of 80 people, API custom manufacturing for early phase development under c-GMP

Sepracor:
Senior Research Chemist

Dr. Dieter Krimmer

Managing Partner

Email: dieter.krimmer@rpd-ch.com
Phone: +41 41 544 1721

Mobile CH: +41 76 328 3337

Mobile D: +49 1761 328 3337

Education:
Chemist, TH Stuttgart

Key experience:
Project Management, Fermentation, Chemical and Formulation Development, Drug Product, Regulatory Experience (FDA, EMEA, Bfarm), Validation, Qualification, Audits and Inspections

Previous Experience:

Independent Consultant:

CMC Management for e.g. Gilead, Trigen

Hofmann La Roche:

Technical Team Leader for the products INVIRASE®, VIRACEPT®, TAMIFLU®

Freelance Partners

Patrick Page, PhD, MBA
Freelance Consultant for RPD

 

Decode Pharma Partners
3 Cours Charlemagne
69002 Lyon, France
Mobile : +33 6 46 80 05 59
Email: patrick.page@decodepharma-partners.com

Homepage: www.decodepharma-partners.com


Education:
PhD, Biochemistry, Medicinal Chemistry, Uni. of Toulouse; 

MBA, Management in Healthcare, INSEEC Paris

Key experience:

Experienced drug developer and biotech entrepreneur. Founder and co-founder of 3 Biotech companies (Genkyotex on French stock market, Epiremed, Conicmeds). Full-time and part-time executive positions (CEO, CSO, CDO/COO) in several early stage biotech companies. Appointed permanent scientific advisor for the Biopark of Brussels South Charleroi (Wallonia region, BE). 22+ years in pharmaceutical industry: Strategic Project Management, Leadership and Execution, Target Validation, Drug Discovery, Medicinal Chemistry, Preclinical Research and Development, ADME/DMPK/Tox. Filed >25 patents, designed IP and in-licensing strategy, and led patent portfolio for several companies. Inventor and key contributor for Nolasiban, OBE-022, Setanaxib. Major contribution in the birth, business plan, business and R&D strategy, discovery and development plan, and fund raising of several biotechs/spin-off either as executive/non-executive member or acting as a freelance consultant (Genkyotex, Epiremed, Epics Therapeutics, Conicmeds, Gepeceron,…). Multiple due diligence for VC firms, Business angels, TTO and research institutions.

Selected Previous Experience: 

Conicmeds SAS (FR): 

CEO, Director of Preclinical Development and CMC. Membrane nanospacers targeting pulmonary obstructive diseases

Epiremed SAS (FR): 

CSO, Director of Drug Discovery. Compounds targeting epigenetic enzymes for cancers

Genkyotex SA (CH):

Senior Research Advisor. R&D process; Metabolic and Ophtalmological programmes.

Serono Pharma (CH) :

Senior Project Director preclinical development; GPCR, Kinases, Ions channels modulators for several therapeutic indications

Astrazeneca (SE) :

Project Director drug discovery programmes; Discovery research on several programmes

Dr. Olaf Mundszinger

Freelance Consultant for RPD

A&O Pharmadienstleistungen

Am Sattel 17

D 79588 Efringen-Kirchen

Germany

Phone: +49 7628 950 3119

Mobile: +49 170 275 0459

Email: o.mundszinger@aopharma.de

Homepage: www.aopharma.de

 

Education:

Chemist University of Freiburg and Saarland

Study of Pharmaceutical Sciences, QP

 

Key experience:

Qualified Person, GMP, Audits, Pharmaceutical Quality System, Quality Control, Quality Assurance, Validation, IMPD Writing

 

Previous Experience:

Develco Pharma: Head QC, Managing director QA, QP

CU Chemie Uetikon: API manufacturing development, QC

Dr. Timo Schmidt

Freelance Consultant for RPD

Managing Director
Talisto GmbH
Neuhofstrasse 18
CH - 8834 Schindellegi

Switzerland


Phone: +41 44 542 11 20
Mobile: +41 79 969 05 38
Email: t.schmidt@talisto.ch 
Homepage: www.talisto.ch


Education: 
Pharmacist, Universities Würzburg and Munich, Germany 
Ph.D. University of Basel, Switzerland
Executive MBA, Instituto de Empresa, Spain 


Key experience: 
Product Development from concept to technology transfer including regulatory processes, Product Strategy and Life Cycle Management, IP Management, Licensing- and Business Development, RP/QP/fvP services (Switzerland), CDMO and CMC Project Management, Start-Up support (food, pharma, cosmetics). 


Previous Experience: 
EffRx:

Chief Scientific Officer, Member of the management board; overseeing R&D, Regulatory Affairs, Drug Safety, Intellectual Property, Technical Operation and Quality Management. Bone diseases, oncology supportive care, metabolic disease (PCOS)


IDC:

Co-founder, CEO and board member; building a product development and CMC service company from scratch (formulation development, analytical services, technology transfer). Various product classes.

 
Aenova:

Director Corporate R&D; global R&D and product development strategy and -services management for Temmler Group (4 R&D sites, 1 built out), business development, client consulting.


Mepha:

Various roles with increasing responsibilities from sourcing of APIs to international tech transfer and product development. 

 
 
Photo 2 Patrick Page.jpg
robert-hett-2019.jpg
Dieter.jpg
timo_face_compressed.jpg
Dr. Olaf Mundszinger

Dr. Goran Westerberg, Ph. D.

Freelance Consultant for RPD

La Crocina Pharmaceutical Consultants Lp

Email: goran.westerberg@crocina.com

Homepage: www.crocina.com

Education:
PhD Radiopharmacology, University of Uppsala, Sweden

Key experience:
>30 years in pharmaceutical industry: Clinical and Regulatory Development, Early (Phase I-IIb) clinical studies, Preclinical Development, Due Diligence evaluations, Project Management. Experience from >600 clinical trials, including 36 FTIH studies.

Previous Experience:

Siena Biotech SpA:

Director, Clinical & Regulatory Development. Neuroscience and Oncology programs.

 

Pfizer/Pharmacia Inc:

Director, Clinical Pharmacokinetics. CNS-, Urology-, Oncology and Cardiovascular programs.

 

Pharmacia & Upjohn:

Senior Research Advisor. R&D process; Clinical and Regulatory Management.

 

Uppsala PET Centre:

Associate Director; Clinical Pharmacology studies.

GW%20pic_edited.jpg